FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs
The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients access to competing lower-cost drugs.
- The Federal Trade Commission announced that it will ramp up enforcement against any illegal bribes and rebate schemes that block patients access to competing lower-cost drugs.
- The agency will use its full range of legal authorities to combat illegal prescription drug practices that foreclose competition and harm patients.
- Todays action should put the entire prescription drug industry on notice: when we see illegal rebate practices that foreclose competition and raise prescription drug costs for families, we wont hesitate to bring our full authorities to bear, said FTC Chair Lina Khan.
- These health plans, usually through prescription drug middlemen like pharmacy benefit managers, use formularies to define which medicines they will cover.